Analyst Price Targets — COCH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 21, 2026 10:02 am | — | H.C. Wainwright | $2.00 | $0.75 | TheFly | Envoy Medical price target lowered to $2 from $2.50 at H.C. Wainwright |
| July 27, 2026 10:08 am | Alex Nowak | Loop Capital Markets | $2.00 | $0.66 | StreetInsider | Lucid Capital Markets Starts Envoy Medical (COCH) at Buy |
| April 3, 2024 8:45 am | Frank Takkinen | Loop Capital Markets | $6.00 | $4.48 | StreetInsider | Envoy Medical (COCH) PT Raised to $6 at Lake Street Capital Markets, 'believe investors will be rewarded for taking a longer-term view' |
| April 3, 2024 8:42 am | Frank Takkinen | Lake Street | $6.00 | $4.48 | TheFly | Envoy Medical price target raised to $6 from $3 at Lake Street |
Latest News for COCH
White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medical ® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, on September 14-16, 2026 at the Lotte New York…
American Bio Medica (OTCMKTS:ABMC - Get Free Report) and Envoy Medical (NASDAQ: COCH - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk. Earnings and Valuation This table compares American
Envoy Medical, Inc. (COCH) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.32 per share a year ago.
Submitted First Module of Modular PMA Application to FDA Subsequent to Quarter End, the Company Reported Positive 12-Month Stage 1 Data Showing Continued Improvement in Speech Perception White Bear Lake, Minnesota--(Newsfile Corp. - August 10, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today reported financial…
Envoy Medical, Inc. (COCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for COCH.
U.S. House Trading
No House trades found for COCH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.